Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-01 Purchase |
2022-12-05 4:48 pm |
Milestone Pharmaceuticals Inc. | MIST | Bharucha David Chief Medical Officer |
10,000 | $4.741 | $47,410 | 10,000 (Direct) |
View |
| 2022-10-19 Purchase |
2022-10-21 7:03 pm |
Milestone Pharmaceuticals Inc. | MIST | Wills Robert James Director |
15,000 | $4.93 | $73,950 | 15,000 (Direct) |
View |
| 2022-10-20 Purchase |
2022-10-21 7:02 pm |
Milestone Pharmaceuticals Inc. | MIST | Pasternak Richard C Director |
10,000 | $5.2 | $52,000 | 10,000 (Direct) |
View |
| 2022-10-20 Purchase |
2022-10-21 7:02 pm |
Milestone Pharmaceuticals Inc. | MIST | Liebert Debra K. Director |
14,000 | $5.2814 | $73,940 | 4,127 (Indirect Direct) |
View |
| 2022-10-19 Purchase |
2022-10-21 7:01 pm |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
15,000 | $5.32 | $79,800 | 15,000 (Direct) |
View |
| 2022-09-07 Purchase |
2022-09-09 4:15 pm |
Milestone Pharmaceuticals Inc. | MIST | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
1,557,346 | $8.71 | $13,564,484 | 4,315,102 (Indirect) |
View |
| 2022-09-07 Sale |
2022-09-09 4:15 pm |
Milestone Pharmaceuticals Inc. | MIST | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
1,557,346 | $8.71 | $13,564,484 | 4,315,102 (Indirect) |
View |
| 2022-05-31 Purchase |
2022-06-01 9:32 pm |
Milestone Pharmaceuticals Inc. | MIST | TRUEX PAUL F Director |
5,000 | $5.6 | $28,000 | 84,556 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-16 Option Award |
2023-02-17 4:52 pm |
N/A 2033-02-16 |
Milestone Pharmaceuticals Inc. | MIST | Muller Lorenz Chief Commercial Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:51 pm |
N/A 2033-02-16 |
Milestone Pharmaceuticals Inc. | MIST | Nelson Jeffrey Edward Chief Operating Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:51 pm |
N/A 2033-02-16 |
Milestone Pharmaceuticals Inc. | MIST | Hasija Amit CFO & EVP of Corp. Development |
130,000 | $0 | 130,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:50 pm |
N/A 2033-02-16 |
Milestone Pharmaceuticals Inc. | MIST | Bharucha David Chief Medical Officer |
185,000 | $0 | 185,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:49 pm |
N/A 2033-02-16 |
Milestone Pharmaceuticals Inc. | MIST | Oliveto Joseph President and CEO |
360,000 | $0 | 360,000 (Direct) |
View |
| 2022-09-14 Other |
2022-09-15 4:30 pm |
N/A N/A |
Milestone Pharmaceuticals Inc. | MIST | Liebert Debra K. Director |
127 | $0 | 254 (Direct) |
View |
| 2022-07-05 Option Award |
2022-08-11 6:05 pm |
N/A 2032-07-05 |
Milestone Pharmaceuticals Inc. | MIST | Pasternak Richard C Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-08-11 6:03 pm |
N/A 2032-07-05 |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-08-11 6:02 pm |
N/A 2032-07-05 |
Milestone Pharmaceuticals Inc. | MIST | Wills Robert James Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-08-11 6:01 pm |
N/A 2032-07-05 |
Milestone Pharmaceuticals Inc. | MIST | Giles Lisa M. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-08-11 6:00 pm |
N/A 2032-07-05 |
Milestone Pharmaceuticals Inc. | MIST | Liebert Debra K. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 9:32 pm |
N/A N/A |
Milestone Pharmaceuticals Inc. | MIST | TRUEX PAUL F Director |
8,016 | $1.12 | 84,556 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 9:32 pm |
N/A 2025-08-26 |
Milestone Pharmaceuticals Inc. | MIST | TRUEX PAUL F Director |
76,780 | $0 | 84,556 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 9:32 pm |
N/A N/A |
Milestone Pharmaceuticals Inc. | MIST | TRUEX PAUL F Director |
822 | $2.66 | 84,556 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-01 9:32 pm |
N/A N/A |
Milestone Pharmaceuticals Inc. | MIST | TRUEX PAUL F Director |
67,942 | $1.54 | 84,556 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 9:47 pm |
N/A 2032-03-21 |
Milestone Pharmaceuticals Inc. | MIST | Oliveto Joseph President and CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 9:47 pm |
N/A 2032-03-21 |
Milestone Pharmaceuticals Inc. | MIST | Hasija Amit CFO & EVP of Corp. Development |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 9:46 pm |
N/A 2032-03-21 |
Milestone Pharmaceuticals Inc. | MIST | Muller Lorenz Chief Commercial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:48 pm |
N/A 2032-02-15 |
Milestone Pharmaceuticals Inc. | MIST | Bharucha David Chief Medical Officer |
330,000 | $0 | 330,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-29 5:40 pm |
N/A 2031-06-14 |
Milestone Pharmaceuticals Inc. | MIST | TRUEX PAUL F Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-29 5:39 pm |
N/A 2031-06-14 |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-29 5:38 pm |
N/A 2031-06-14 |
Milestone Pharmaceuticals Inc. | MIST | Pasternak Richard C Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-29 5:37 pm |
N/A 2031-06-14 |
Milestone Pharmaceuticals Inc. | MIST | Liebert Debra K. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-29 5:35 pm |
N/A 2031-06-14 |
Milestone Pharmaceuticals Inc. | MIST | Giles Lisa M. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-29 5:34 pm |
N/A 2031-06-14 |
Milestone Pharmaceuticals Inc. | MIST | Wills Robert James Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 8:41 pm |
N/A 2031-03-24 |
Milestone Pharmaceuticals Inc. | MIST | Oliveto Joseph President and CEO |
670,000 | $0 | 670,000 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 8:40 pm |
N/A 2031-03-24 |
Milestone Pharmaceuticals Inc. | MIST | Plat Francis Chief Medical Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 8:39 pm |
N/A 2031-03-24 |
Milestone Pharmaceuticals Inc. | MIST | Hasija Amit CFO & EVP of Corp. Development |
240,000 | $0 | 240,000 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 8:37 pm |
N/A 2031-03-24 |
Milestone Pharmaceuticals Inc. | MIST | Muller Lorenz Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:02 pm |
N/A 2030-10-01 |
Milestone Pharmaceuticals Inc. | MIST | Wills Robert James Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:01 pm |
N/A 2030-10-01 |
Milestone Pharmaceuticals Inc. | MIST | Giles Lisa M. Director |
30,000 | $0 | 30,000 (Direct) |
View |